PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 70,000+ professionals | Subscribe TOP STORIES “You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape Read More » Fresenius Signs WuXi Biologics Agreement to Access Up to 37 Biosimilar Candidates Cambrex Breaks Ground on $120M Expansion to Add 160,000 Liters of API Capacity AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions Asymchem Completes First USFDA Pre-Approval Inspection at Tianjin TIDES Facility Codis Begins Construction on PSD-4 Expansion to Increase Spray Drying Capacity Lonza Expands Bioconjugation Manufacturing Capacity in Visp with Three New Suites From Development to Commercial Reality: Building Scalable Biologics Processes from the Start Katalyze AI’s Path to Same-Day Deviation Investigations Experic Secures Irish GMP Certification for Clinical Trial Supply Facility Piramal Pharma Solutions Wins Patient Centricity Award for Pithampur Dashboard PSI CRO Partners with Appian to Deploy AI-Powered Clinical Trial Site Selection Platform ProtaGene Appoints Former Merck KGaA CDMO Executive Matthias Bucerius as CEO Transpharmation Acquires OrganoTherapeutics to Combine Translational In Vivo CRO Expertise With Human Stem Cell-Derived Organoid Technology Gannet BioChem Partners With Re-Vana on cGMP Polymer Manufacturing Adalvo Acquires Romiplostim Biosimilar Program From Enzene More news + insights Fresenius Signs WuXi Biologics Agreement to Access Up to 37 Biosimilar Candidates Cambrex Breaks Ground on $120M Expansion to Add 160,000 Liters of API Capacity AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions PODCASTS “You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026 SPOTLIGHT Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI + Digital Maturity in Contract Manufacturing 2026: Report and Exclusive Webinar AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] UPCOMING EVENTS AI + Digital Maturity in Contract Manufacturing 2026: Report and Exclusive Webinar MASTERCLASS: De-Risking Technology Transfer in OSD External Manufacturing Leaders West 2027 External Manufacturing Leaders Dublin 2026
“You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape Read More »
AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions
Transpharmation Acquires OrganoTherapeutics to Combine Translational In Vivo CRO Expertise With Human Stem Cell-Derived Organoid Technology
AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions
“You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape
State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026